December 13, 2011
SAN DIEGO, Calif.–(BUSINESS WIRE)–Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today reported results from the final five-year follow-up analysis of the international, multicenter, Phase III VISTA1 trial. The analysis assessed overall survival (OS) after treatment with VELCADE (bortezomib) in combination with melphalan and prednisone (VcMP) versus melphalan and [...]
Read the full article →
December 13, 2011
Galway Advertiser, December 01, 2011. the World Health Organization lists hundreds of conditions that can be treated with acupuncture. Some of the conditions that affect breathing are infections, such as colds and flu, bronchitis, asthma, and eye, ear, nose, throat, and sinus infections. Patients with lung cancer could find acupuncture useful to strengthen their immunity [...]
Read the full article →